Nifuroxazide in treatment of salmonellosis in children
P.K. SOLDATKIN1, N.A. MARUNICH1, О.V. GRIBANOVA2, S.V. PSHENICHNIKOV2
1Amur State Medical Academy, 95 Gorkiy St., Blagoveshchensk, Russian Federation, 675000
2Amur Region Infectious Hospital, 15 Bolnichnaya St., Blagoveshchensk, Russian Federation, 675000
Soldatkin P.K. — Assistant Lecturer of the Department of Infectious Diseases with courses in Epidemiology and Dermatovenerology, tel. +7-962-294-57-37, e-mail: pavel.soldatkin.53@mail.ru
Marunich N.A. — Cand. Med, Sc., Associate Professor, Head of the Department of Infectious Diseases with Epidemiology and Dermatovenerology, tel. +7-914-386-46-75, e-mail: natali.marunich@yandex.ru
Gribanova O.V. — physician of the Department of Intestine Infections in Children, tel. +7-962-284-94-61, e-mail: olya.gribanova.80@mail.ru
Psheninchnikov S.V. — Head of the Department of Intestine Infections in Children, tel. +7-924-673-15-56, e-mail: olya.gribanova.80@mail.ru
This article is devoted to the search of highly effective antibacterial drugs with minimal side effects for children with salmonellosis. The correct antibiotic therapydetermines the effectiveness of the main symptoms’relief. The efficiency of nifuroxazide (group N) was assessed in comparison with antibiotics (group A) in the treatment of salmonellosis complex. In group A patients with a smooth course of the diseasewere selected, and they were treated with one course of antibiotics. High clinical efficacy of nifuroxazidein relieving the main symptoms of the diseasewas proved, which has a positive impact on the duration of hospital stay. The results of our study are consistent with the findings of other researchers, which allowsto recommendnifuroxazide for a wide usage in the treatment of children with acute intestinal infections caused by pathogenic organisms.
Key words: nifuroxazide, salmonellosis, children, treatment.
REFERENCES
1. Skvortsov V.V. Intestinal dysbiosis and antibiotic-diarrhea. Diagnosis and treatment. Lechashchiy vrach, 2008, no. 2, pp. 43-47 (in Russ.).
2. Turco., Bernet J.-P., Mapt J. et al. Incidence and risk factors of antibiotic associated diarrhea in an patients in pediatric population. J. Pediatr Gastroenterol Nutr., 2003, 37 (1), rr. 28-6.
3. Akhmadeeva E.N., Nizhevich N.N, Amirova V.R. Antibiotic-diarrhea in children. Rossiyskiy pediatricheskiy zhurnal, 2010, no. 1, pp. 32-38 (in Russ.).
4. Soldatkin P.K., Tolstopyatova A.A. Antibiotic-associated syndrome in children with acute intestinal infections caused by opportunistic pathogens. Dal’nevostochnyy zhurnal infektsionnoy patologii, 2012, no. 21, pp. 121-126 (in Russ.).
5. Grishchenko E.B. The role of antimicrobial therapy in violation of intestinal microflora. Correction technique. Consilium medicum, vol. 13, no. 4, pp. 54-57 (in Russ.), available at: www.consiliummedicum.com.
6. Soldatkin P.K., Tolstopyatova A.A., Marunich N.A. The modern approach to antibacterial therapy of enterobacteriosis in children. Modern problems of nanobacteriology. The 8th Russia-China pharmaceutical forum. Blagoveshchensk, 2011. Pp. 108-110.
7. Wistrom J., Noppby S.R., Myhpe E.B. Frequency of antibiotic-associated diarrhea in 2462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemotherapy.
8. Ayyagari A., Agarwal J., Jarg A. Antibiotic-associated diarrhea: infectious causes. Indian J. Med. Microbiol., 2003, vol. 21 (1), pp. 6-11.
9. Gorelov A.V., Usenko Yu.V., Kadzhaeva E.P. et al. Evaluation of the clinical efficacy Enterofuril in the complex therapy of acute intestinal infections in children and its effect on the intestine mikrobioz. Infektsionnye bolezni, 2006, vol. 4, no. 6, pp. 47-50 (in Russ.).
10. Sapozhnikov V.G., Burlikina G.V., Burlikin V.V. Enterofuril in the treatment of acute intestinal infections in children. Rossiyskiy vestnik perinatologii i pediatrii, 2008, no. 3, pp. 73-76 (in Russ.).
11. Soldatkin P.K., Gavrilov V.A., Marunich N.A. Enterofuril v kompleksnoy terapii detey s pishchevoy toksikoinfektsiey, vyzvannoy B.cepacia [Enterofuril in the complex therapy of children with food poisoning caused by B.cepacia]. Materialy II ezhegodnogo vserossiyskogo kongressa po infektsionnym boleznyam, 2010. Pp. 296-297.
12. Kvetnaya A.S., Bekhtereva M.K., Zhelezova L.I. et al. Use of tsikloferona in the complex therapy of Salmonella infection in children. Antibiotiki i khimioterapiya, 2012, no. 3, pp. 9-16 (in Russ.).
13. Milyutina L.N., Gur’eva O.V., Rozhnova S.I. et al. The evolution of drug resistance of Salmonella enteritidis, isolated from children. Epidemiologiya i infektsionnye bolezni, 2008, no. 2, pp. 44-47 (in Russ.).
14. Ivanov N.S. Modern views on antibiotic resistance and antibiotic therapy salmonella. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya, 2009, no. 4, pp. 305-326 (in Russ.).
15. Gorelov N.V., Usenko Yu.V., Ploskireva A.L. The role of probiotics in the prevention of diarrhea associated with taking antibiotics. Pediatriya (Consilium medicum), 2011, no. 4, pp. 27-30 (in Russ.).